Showing results (1-10 of 116) with videos related to
Sort By:
Pageof 12
Drugs|January 1, 1995
Classification and structure-activity relationships of fluoroquinolonesA Bryskier, J F ChantotPathologie-Biologie|June 1, 1985
[HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin]J F Chantot, A BryskierPathologie-Biologie|June 1, 1985
[Cefpirome (HR 810). A new broad spectrum cephalosporin]A Bryskier, J F ChantotThe Journal of Antimicrobial Chemotherapy|October 1, 1985
Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparisonJ F Chantot, A BryskierPresse Medicale (Paris, France : 1983)|December 21, 1985
[Therapeutic prospects of new fluoroquinolones]A Bryskier, J F Chantot, P VeyssierThe Journal of Antibiotics|May 1, 1986
Antibacterial activity of roxithromycin: a laboratory evaluationJ F Chantot, A Bryskier, J C GascAntimicrobial Agents and Chemotherapy|August 1, 1992
Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactamJ F Chantot, M Klich, G Teutsch, et al.Pathologie-Biologie|October 1, 1991
[Study of the bactericidal effect of cefpodoxime using an in vitro pharmacokinetic model]A Caisson, J F ChantotPathologie-Biologie|January 1, 1991
[RU 51807 (cefpodoxime proxetil). In vitro and in vivo antibacterial activity of a new orally administered active cephalosporin]J F Chantot, P MauvaisClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 16, 2002
Viridans group streptococci: a reservoir of resistant bacteria in oral cavitiesA BryskierPageof 12